National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Section on Fibrotic Disorders
The mission of the lab is to understand the cellular and molecular mechanisms involved in the development and progression of fibrosis, to explore novel therapeutic targets and to develop effective pharmacotherapies for fibrotic disorders of different etiologies, including alcohol use disorders. We are particularly interested in pursuing a multi-target therapeutic approach to improve treatment efficacy by simultaneously engaging multiple pathogenic...
Webinar - Interagency Work Group on Drinking and Drug Use in Women and Girls
Friday, October 1, 2021, 11:00 am EDT to Friday, October 1, 2021, 12:00 pm EDT
Webinar Title: “Reductions in Drinking as Measured by WHO Risk Drinking Levels and Associations with Health and Functioning: Consistency in Population Studies and Clinical Trials” Speakers: Deborah S. Hasin, PhD. Department of Psychiatry, Columbia University and New York State Psychiatric Institute Katie Witkiewitz, PhD. Center on Alcohol, Substance use, And Addictions (CASAA), University of New Mexico Date: Friday, October 1...
Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College
Title Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College Contact Mike Hilton, Ph.D., Division of Epidemiology and Prevention Research Purpose The purpose of this future grant application solicitation is to balance the NIAAA research portfolio by supporting research on alcohol misuse among persons aged 18 to 29 who are not enrolled in...
Alcohol Consumption During the Pandemic: Extending Longitudinal Survey and Analysis
Gregory Bloss, M.A., M.P.P./ Program Director, Division of Epidemiology and Prevention Research Acquisition Type/Actions The National Institute on Alcohol Abuse and Alcoholism (NIAAA) requests approval from the NIAAA Advisory Council to allow Research Triangle Institute (RTI) International to submit a contract proposal in response to a sole-source request for proposal. This acquisition, for other than full and open competition...
Section on Medicinal Chemistry
The principal mission of the lab is to develop selective probes and drug-like molecules to enable the study of molecular mechanisms in alcohol associated diseases. The lab aims to use medicinal chemistry and chemical biology approaches to design, synthesize and biologically characterize novel druggable tools for select GPCRs and enzymatic drug targets implicated in pain, inflammatory and fibrotic disorders. Our...
Janani Prabhakar, NIDA
Janani Prabhakar, Ph.D. Program Officer HEALthy Brain and Child Development (HBCD) Study Division of Neuroscience and Behavior National Institute on Drug Abuse (NIDA) National Institutes of Health 6001 Executive Boulevard, Room 5163 Bethesda, MD 20892-9589 Phone: (301) 827-4729 Email: janani.prabhakar@nih.gov Biographical Summary Dr. Prabhakar received her Ph.D. from Rutgers University, New Brunswick, NJ and completed a postdoctoral fellowship at the...